![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/08/2909366/0/en/AB-Science-announces-positive-results-of-its-Phase-2-study-evaluating-masitinib-in-Covid-19.html
https://www.globenewswire.com/news-release/2024/06/28/2905749/0/en/AB-Science-provides-an-update-on-the-application-for-conditional-marketing-authorisation-of-masitinib-in-ALS.html
https://www.globenewswire.com/news-release/2024/05/31/2891592/0/en/AB-Science-is-providing-a-summary-of-the-live-webcast-held-on-May-30-2024-giving-an-update-on-the-application-for-conditional-marketing-authorization-of-masitinib-in-ALS.html
https://www.globenewswire.com/news-release/2024/05/29/2890131/0/en/AB-Science-provides-an-update-on-the-application-for-conditional-marketing-authorisation-of-masitinib-in-ALS.html
https://www.globenewswire.com/news-release/2024/05/15/2882796/0/en/AB-Science-reports-its-revenues-for-the-year-2023-and-provides-an-update-on-its-activities.html
https://www.globenewswire.com/news-release/2024/05/13/2880740/0/en/AB-Science-announces-issuance-of-a-European-patent-for-masitinib-in-the-treatment-of-severe-mastocytosis-with-protection-until-2036.html
https://www.globenewswire.com/news-release/2024/05/07/2877013/0/en/AB-Science-A-new-publication-in-the-medical-journal-Muscle-Nerve-validates-the-use-of-the-rate-of-decline-of-ALSFR-S-score-%CE%94FS-for-the-design-of-clinical-studies-and-the-treatment-.html
https://www.globenewswire.com/news-release/2024/05/02/2874558/0/en/AB-Science-The-Paris-Court-of-Appeal-confirms-the-acquittal-of-the-CEO-of-AB-Science-Alain-Moussy-and-reduces-the-amount-of-the-financial-penalty-imposed-on-AB-Science.html
https://www.globenewswire.com/news-release/2024/04/30/2872646/0/en/AB-Science-announces-a-slight-delay-in-the-publication-of-its-2023-annual-financial-report.html
https://www.globenewswire.com/news-release/2024/04/03/2857229/0/en/AB-Science-announces-that-Health-Canada-has-granted-eligibility-for-reconsideration-request-for-masitinib-in-ALS.html